Agree. All of Borje's lab work has been validated in the clinic. Zan continues to perform exactly as expected.
Time to validate some of our own blue sky opportunity... Which could have happened already if we pursued the RC110 P2b Breast Cancer trial that was planned for 2022.
Can't keep watching the pie get bigger. Take a bite!
General Comments / Chat, page-9801
-
- There are more pages in this discussion • 2,247 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.57 |
Change
0.050(3.29%) |
Mkt cap ! $274.4M | |||
| Open | High | Low | Value | Volume |
| $1.56 | $1.61 | $1.56 | $72.59K | 45.80K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7920 | $1.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.59 | 3500 | 2 |
View Market Depth
| Last trade - 12.58pm 08/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |